Improving Federal Oversight of HHS Grantees

The US Department of Health and Human Services considers ways to mitigate the risk of poor performance or misuse of funds by grantees.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

IMAGE, PUBLICDOMAINPICTURESThe US federal department that awards more than $400 billion in grants to researchers every year is seeking ways to better oversee funding recipients. The key to this, according to a report released this week (September 2) by the Department of Health and Human Services’s (HHS) Office of the Inspector General (OIG), is better information sharing among 13 HHS awarding agencies, including the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). Such an improvement could help funders identify and deal with researchers who underperform or misuse grant money. “Awarding agencies’ grant officials use various sources of information and communication to mitigate grantee risks; however, grant officials noted limitations in some instances,” the report read.

In surveying grant officials at different HHS agencies, the OIG found that reports reviewed to mitigate the risk of grant misuse are often late and incomplete, identified lapses in communication between grant management officers, and uncovered a failure of some agencies to submit National External Audit Review Center memoranda. It also found that fewer than half of the HHS awarding agencies share information about grantees with other agencies.

In its report, the OIG recommended that funding agencies improve their use of databases designed to monitor grantees, establish a department-wide repository for adverse information from audits of grantees, and enhance information sharing across HHS.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies